2 years ago By Suzana — Following a deal first announced in September, Merck (NYSE:MRK) says it has successfully completed the acquisition of Acceleron Pharma (NASDAQ:XLRN). "This

3 years ago By Olachi — Merck, the pharmaceutical giant with sizable operations in West Point, is acquiring Acceleron Pharma for around $11.5 billion, according to a staff report